The ALIAS phase I trial: A dose-escalation and safety study of albumin therapy for acute ischemic stroke

被引：0
|
作者：
Ginsberg, MD
Hill, MD
Palesch, YY
Ryckborst, KJ
Tamariz, D
机构：
[1] Univ Miami, Sch Med, Miami, FL 33152 USA
[2] Univ Calgary, Calgary, AB T2N 1N4, Canada
[3] Med Univ S Carolina, Charleston, SC 29425 USA
来源：
STROKE | 2005年 / 36卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：420 / 420
页数：1
相关论文
共 50 条
  • [21] Optimal phase I dose-escalation trial designs in oncology-A simulation study
    Gerke, Oke
    Siedentop, Harald
    STATISTICS IN MEDICINE, 2008, 27 (26) : 5329 - 5344
  • [22] Collagenase Total Occlusion-1 (CTO-1) Trial A Phase I, Dose-Escalation, Safety Study
    Strauss, Bradley H.
    Osherov, Azriel B.
    Radhakrishnan, Sam
    Mancini, G. B. John
    Manners, Allison
    Sparkes, John D.
    Chisholm, Robert J.
    CIRCULATION, 2012, 125 (03) : 522 - 528
  • [23] EXACT Trial: Results of the Phase 1 Dose-Escalation Study
    Povsic, Thomas J.
    Henry, Timothy D.
    Traverse, Jay H.
    Anderson, R. David
    Answini, Geoffrey A.
    Sun, Benjamin C.
    Arnaoutakis, George J.
    Boudoulas, Konstantinos D.
    Williams, Adam R.
    Dittrich, Howard C.
    Tarka, Elizabeth A.
    Latter, David A.
    Ohman, E. Magnus
    Peterson, Mark W.
    Byrnes, Dawn
    Pepine, Carl J.
    DiCarli, Marcelo F.
    Crystal, Ronald G.
    Rosengart, Todd K.
    Mokadam, Nahush A.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2023, 16 (08) : E012997
  • [24] Phase I Dose-Escalation Study of Proton Beam Therapy for Inoperable Hepatocellular Carcinoma
    Kim, Tae Hyun
    Park, Joong-Won
    Kim, Yeon-Joo
    Kim, Bo Hyun
    Woo, Sang Myung
    Moon, Sung Ho
    Kim, Sang Soo
    Koh, Young-Hwan
    Lee, Woo Jin
    Park, Sang Jae
    Kim, Joo-Young
    Kim, Dae Yong
    Kim, Chang-Min
    CANCER RESEARCH AND TREATMENT, 2015, 47 (01): : 34 - 45
  • [25] Plasmin (Human) Administration in Acute Middle Cerebral Artery Ischemic Stroke: Phase 1/2a, Open-Label, Dose-Escalation, Safety Study
    Mitchell, Peter J.
    Yan, Bernard
    Brozman, Miroslav
    Ribo, Marc
    Marder, Victor
    Courtney, Kecia L.
    Saver, Jeffrey L.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2017, 26 (02): : 308 - 320
  • [26] Safety and immunogenicity in a phase I dose-escalation BPV-1VLP vaccine trial in horses
    Kirnbauer, R.
    Brandt, S.
    Shafti-Keramat, S.
    Hainisch, E. K.
    WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 : 17 - 18
  • [27] A Phase I, Dose-escalation Trial Evaluating the Safety and Efficacy of Emulsified Isoflurane in Healthy Human Volunteers
    Huang, Han
    Li, Rui
    Liu, Jin
    Zhang, Wensheng
    Liao, Tianzhi
    Yi, Xiaoqian
    ANESTHESIOLOGY, 2014, 120 (03) : 614 - 625
  • [28] Fractionated carboplatin radiosensitization - A phase I dose-escalation study
    Koukourakis, MI
    Stefanaki, I
    Giatromanolaki, A
    Frangiadaki, C
    Armenaki, A
    Georgoulias, V
    Koumandakis, E
    Kranidis, A
    Helidonis, E
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (06): : 595 - 601
  • [29] A phase I dose-escalation study of NK012
    Burris, H. A., III
    Infante, J. R.
    Spigel, D. R.
    Greco, F. A.
    Thompson, D. S.
    Matsumoto, S.
    Kawamura, S.
    Jones, S. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [30] Phase I dose-escalation, safety, and CNS pharmacokinetic study of dexanabinol in patients with brain cancer
    Juarez, Tiffany M.
    Piccioni, David
    Rose, Lara
    Nguyen, Angel
    Brown, Bradley
    Kesari, Santosh
    NEURO-ONCOLOGY ADVANCES, 2021, 3 (01)
12345